# Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

> **NCT04511000** · PHASE4 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 250 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Lipilou®(generic atorvastatin drug) 20 mg
- **DRUG:** Lipilou®(generic atorvastatin drug) 10 mg

## Key facts

- **NCT ID:** NCT04511000
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-11
- **Primary completion:** 2019-05-20
- **Final completion:** 2019-05-20
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04511000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04511000, "Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04511000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*